PRAX — Praxis Precision Medicines Cashflow Statement
0.000.00%
Last trade - 00:00- $6.72bn
- $6.42bn
- $8.55m
Annual cashflow statement for Praxis Precision Medicines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -61.8 | -167 | -214 | -123 | -183 |
| Depreciation | |||||
| Non-Cash Items | 5.91 | 26.2 | 30.3 | 25.7 | 39.8 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.24 | 16.1 | -1.78 | -14 | 10.9 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -52.6 | -125 | -185 | -111 | -132 |
| Capital Expenditures | 0 | -1.05 | -0.444 | -0.05 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -139 | 97.3 | 39 | -248 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0 | -141 | 96.9 | 39 | -248 |
| Financing Cash Flow Items | — | -0.575 | -0.522 | -0.137 | -0.308 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 304 | 108 | 10.5 | 91.9 | 514 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 252 | -157 | -77.7 | 19.7 | 134 |